1-Jahres-Chart (nicht börsennotiert)
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CORNERSTONE THERAPEUTICS Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 98,00 | -0,05 % | Gilead Sciences: The Centrifuge Sessions: Driving Innovation and Investment in Cancer Research | NORTHAMPTON, MA / ACCESS Newswire / April 3, 2025 / We're focused on driving innovation in virology, oncology and immunology - and that includes investing in world-class science to change the way cancer... ► Artikel lesen | |
| ZOETIS | 139,56 | +0,66 % | Zoetis Aktie: Eine Zwischenbilanz der aktuellen Jahre | Die Zoetis Aktie verzeichnete am 22. März 2025 einen leichten Anstieg von 0,32% auf 149,93 EUR. Dies entspricht einem Zuwachs von 0,48 EUR gegenüber dem vorherigen Handelstag. Trotz dieser positiven... ► Artikel lesen | |
| INCYTE | 55,90 | +0,94 % | Incyte Stock: Is INCY Outperforming the Health Care Sector? | ||
| AMARIN | 0,368 | -0,54 % | Amarin Corporation plc: New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor ... | DUBLIN and BRIDGEWATER, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that additional in vitro mechanistic data with eicosapentaenoic acid (EPA) will... ► Artikel lesen | |
| CASSAVA SCIENCES | 1,107 | -7,17 % | Notable healthcare headlines for the week: J&J, GSK, Merck, and Cassava Sciences in focus | ||
| LIGAND PHARMACEUTICALS | 90,00 | -1,10 % | ROUNDUP: Ligand Pharma Slips To Loss In Q4; Confirms FY25 Outlook | WASHINGTON (dpa-AFX) - Biopharmaceutical company Ligand Pharmaceuticals, Inc. (LGND), while reporting a loss in its fourth quarter, compared to prior year's profit, on Thursday confirmed fiscal... ► Artikel lesen | |
| ACHIEVE LIFE SCIENCES | 2,210 | +11,17 % | Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program | Reiterates Planned Cytisinicline NDA Submission Expected at the End of Q2 2025 Company to Host Conference Call at 8:30 AM EDT Today, Tuesday, March 11, 2025 SEATTLE and VANCOUVER, British... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 284,00 | -1,18 % | AKTIONÄR-Hot-Stock Madrigal: Erneute Übernahmegerüchte - Aktie mit Kurssprung | Am späten Freitagabend hat die Aktie des Biotech-Unternehmens Madrigal einen starken Kursanstieg verzeichnet. Erneut halten sich Gerüchte um die Gesellschaft, die mit Rezdiffra (Resmetirom) die erste... ► Artikel lesen | |
| SEELOS THERAPEUTICS | 2,000 | 0,00 % | NSE - SEELOS THERAPEUTICS, INC. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| ENZON PHARMACEUTICALS | 0,080 | 0,00 % | ENZON PHARMACEUTICALS, INC. - 8-K, Current Report | ||
| TALPHERA | 0,477 | +2,69 % | Talphera, Inc.: Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update | The U.S. Food and Drug Administration (FDA) agreed to reduce the number of patients in the NEPHRO CRRT study from 166 to 70
Talphera expects the registrational NEPHRO... ► Artikel lesen | |
| RIGEL PHARMACEUTICALS | 15,300 | -3,16 % | Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | SOUTH SAN FRANCISCO, Calif., April 4, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant... ► Artikel lesen | |
| ANI PHARMACEUTICALS | 61,00 | -1,61 % | ANI Pharmaceuticals Launches Nitazoxanide Tablets 500 Mg | WASHINGTON (dpa-AFX) - ANI Pharmaceuticals, Inc. (ANIP), Wednesday announced the launch of Nitazoxanide Tablets, 500 mg that are the generic version of the reference listed drug Alinia.Nikhil... ► Artikel lesen | |
| SAVARA | 2,640 | +1,54 % | Savara: Loan & Security Agreement Signed For Up To $200 Million With Hercules Capital | ||
| MOLECULAR TEMPLATES | 0,107 | -0,56 % | Molecular Templates, Inc.: Molecular Templates Announces Notice of Delisting and Failure to Satisfy Continued Listing Rules | AUSTIN, Texas, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, "Molecular Templates," or "MTEM" or the "Company"), a clinical-stage biopharmaceutical company focused on... ► Artikel lesen |
Das Unternehmen CORNERSTONE THERAPEUTICS INC kann der Branche Pharma zugeordnet werden.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CORNERSTONE THERAPEUTICS INC finden Sie auf Wallstreet Online.
